197
Views
5
CrossRef citations to date
0
Altmetric
Research Article

The analysis of pneumatic atomization of Newtonian and non-Newtonian fluids for different medical nebulizers

, &
Pages 1999-2010 | Received 26 Apr 2017, Accepted 18 Jul 2017, Published online: 01 Aug 2017

References

  • Newman SP, Clarke SW. Therapeutic aerosols 1-physical and practical considerations. Thorax. 1983;38:881–886.
  • Martin AR, Gleske J, Katz IM, et al. Laser diffraction characterization of droplet size distributions produced by vibrating mesh nebulization in air and a helium–oxygen mixture. J. Aerosol Sci. 2010;41:1159–1166.
  • Le Brun PPH, de Boer AH, Heijerman HGM, et al. A review of the technical aspects of drug nebulization. Pharm World Sci. 2000;22:75–81.
  • Beck-Broichsitter M, Kleimann P, Schmeh T, et al. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers. Eur J Pharm Biopharm. 2012;82:272–280.
  • Flament MP, Leterme P, Gayot A. Study of the technological parameters of ultrasonic nebulization. Drug Dev Ind Pharm. 2001;27:643–649.
  • Ari A, Hess D, Myers TR, et al. Guide to aerosol delivery devices for respiratory therapists. 2nd ed. Texas: American Association for Respiratory Care; 2009.
  • Elliott D, Dunne P. A guide to aerosol delivery devices for physicians, nurses, pharmacists, and other health care professionals. Texas: American Association for Respiratory Care; 2011.
  • Khilnani GC, Banga A. Aerosol therapy. Indian J Chest Dis Allied Sci. 2008;50:209–220.
  • Broniarz-Press L, Sosnowski TR, Matuszak M, et al. The effect of shear and extensional viscosities on atomization of Newtonian and non-Newtonian fluids in ultrasonic inhaler. Int. J. Pharm. 2015;485:41–49.
  • Morén F. Dosage forms and formulations for drug administration to the respiratory tract. Drug Dev Ind Pharm. 1987;13:695–728.
  • McConville JT, McInnes FJ, Ross AC. Preface for innovative inhalation technologies-special edition. Drug Dev Ind Pharm. 2008;34:911–912.
  • Watts AB, McConville JT, Williams IIIRO. Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev Ind Pharm. 2008;34:913–922.
  • Cipolla DC, Gonda I. Formulation technology to repurpose drugs for inhalation delivery. Drug Discov Today Ther Strateg. 2011;8:123–130.
  • Watts AB, Williams RO, III, Peters JI. Recent developments in drug delivery to prolong allograft survival in lung transplant patients. Drug Dev Ind Pharm 2009;35:259–271.
  • Sinha B, Mukherjee B. Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model. Drug Dev Ind Pharm. 2012;38:171–179.
  • Willis L, Hayes D Jr, Mansour HM. Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery. Lung. 2012;190:251–262.
  • Olveira C, Muñoz A, Domenech A. Nebulized therapy. SEPAR Year. Arch Bronconeumol. 2014;50:535–545.
  • Zhou QT, Tang P, Leung SSY, et al. Emerging inhalation aerosol devices and strategies: where are we headed? Adv Drug Deliv Rev. 2014;75:3–17.
  • Devrim B, Bozkır A, Canefe K. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations. Drug Dev Ind Pharm. 2011;37:1376–1386.
  • Akdag Cayli Y, Sahin S, Buttini F, et al. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients. Drug Dev Ind Pharm. 2017;43:1378–1389.
  • Adi H, Young PM, Chan HK, et al. Controlled release antibiotics for dry powder lung delivery. Drug Dev Ind Pharm. 2010;36:119–126.
  • Amirav I. Aerosol therapy. Aerosol Terapia Ital J Pediatr. 2004;30:147–156.
  • Marianecci C, Di Marzio L, Rinaldi F, et al. Pulmonary delivery: innovative approaches and perspectives. J Biomater Nanobiotechnol. 2011;2:567–575.
  • Pahwa R, Pankaj G, Singh M, et al. Nebulizer therapy: a platform for pulmonary drug delivery. Der Pharmacia Sinica. 2012;3:630–636.
  • Lang RJ. Ultrasonic atomization of liquids. J Acoust Soc Am. 1962;34:6–8.
  • McCallion ONM, Taylor KMG, Thomas M, et al. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharm Res. 1995;12:1682–1688.
  • McCallion ONM, Taylor KMG, Thomas M, et al. The influence of surface tension on aerosols produced by medical nebulisers. Int J Pharm. 1996;129:123–136.
  • Ferron GA, Busch B, Gebhart J, et al. Evaporation of aerosols produced with eleven jet nebulizers. J Aerosol Sci. 1996;27:381–382.
  • Flament MP, Leterme P, Burnouf T, et al. Jet nebulisation: influence of dynamic conditions and nebuliser on nebulisation quality. Application to the α1 protease inhibitor. Int J Pharm. 1997;148:93–101.
  • Weber A, Morlin G, Cohen M, et al. Effect of nebulizer type and antibiotic concentration on device performance. Pediatr Pulmonol. 1997;23:249–260.
  • Steckel H, Eskandar F. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. Eur J Pharm Sci. 2003;19:443–455.
  • Vecellio L, Abdelrahi ME, Montharu J, et al. Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin. J Cyst Fibros. 2011;10:86–92.
  • Elhissi A, Hidayata K, Phoenix DA, et al. Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology. Int J Pharm. 2013;444:193–199.
  • Najlah M, Vali A, Taylor M, et al. A study of the effects of sodium halides on the performance of air-jet and vibrating-mesh nebulizers. Int J Pharm. 2013;456:520–527.
  • Najlah M, Parveen I, Alhnan MA, et al. The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers. Int J Pharm. 2014;461:234–241.
  • Niven RW, Prestrelski SJ, Treuheit MJ, et al. Protein nebulization II. Stabilization of G-CSF to air-jet nebulization and the role of protectants. Int J Pharm. 1996;127:191–201.
  • Vecellio L, Kippax P, Rouquette S, et al. Influence of realistic airflow rate on aerosol generation by nebulizers. Int J Pharm. 2009;371:99–105.
  • Ochowiak M, Doligalski M, Broniarz-Press L, et al. Characterization of sprays for thermo-stabilized pneumatic nebulizer. Eur J Pharm Sci. 2016;85:53–58.
  • McCallion ONM, Patel MJ. Viscosity effects on nebulisation of aqueous solutions. Int J Pharm. 1996;130:245–249.
  • Avvaru B, Patil MN, Gogate PR, et al. Ultrasonic atomization: effect of liquid phase properties. Ultrasonics. 2006;44:146–158.
  • Ghazanfari T, Elhissi AMA, Ding Z, et al. The influence of fluid physicochemical properties on vibrating-mesh nebulization. Int J Pharm. 2007;339:103–111.
  • Dalmoro A, d’Amore M, Barba AA. Droplet size prediction in the production of drug delivery microsystems by ultrasonic atomization. Transl Med UniSa. 2013;7:6–11.
  • Broniarz-Press L, Ochowiak M, Matuszak M, et al. The effect of shear and extensional viscosity on atomization in medical inhaler. Int J Pharm. 2014;468:199–206.
  • Trouton FT. On the coefficient of viscous traction and its relation to that of viscosity. Proc Roy Soc. 1906;1:426–440.
  • Petrie CJS. Extensional viscosity: A critical discussion. J Non-Newtonian Fluid Mech. 2006;137:15–23.
  • Mun RP, Byars JA, Boger DV. The effects of polymer concentration and molecular weight on the breakup of laminar capillary jets. J Non-Newtonian Fluid Mech. 1998;74:285–297.
  • Mun PR, Young BW, Boger DV. Atomisation of dilute polymer solutions in agricultural spray nozzles. J Non-Newtonian Fluid Mech. 1999;83:163–178.
  • Różańska S, Broniarz-Press L, Różański J, et al. Extensional viscosity of o/w emulsion stabilized by polysaccharides measured on the opposed-nozzle device. Food Hydrocoll. 2012;32:130–142.
  • Takemoto H, Ito M, Shiraki T, et al. Sedative effects of vapor inhalation of agarwood oil and spikenard extract and identification of their active components. J Nat Med. 2008;62:41–46.
  • Ito K, Ito M. Sedative effects of vapor inhalation of the essential oil of Microtoena patchouli and its related compounds. J Nat Med. 2011;65:336–343.
  • Winnicka K. Leki okulistyczne w aptece – nowe technologie [Ophthalmic drugs in a pharmacy - new technologies]. Gazeta Farmaceutyczna. 2008;7:30–32. Polish.
  • Fu J, Fiegel J, Krauland E, et al. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials. 2002;23:4425–4433.
  • Lefebvre AH. Atomization and sprays. New York, NY: Hemisphere Publishing Corporation; 1989.
  • Azzopardi BJ. Measurements of drop sizes. Int J Heat Mass Transf. 1979;22:1245–1279.
  • Ng SL, Mun RP, Boger DV, et al. Extensional viscosity measurements of dilute solutions of various polymers. J Non-Newtonian Fluid Mech. 1996;65:291–298.
  • Harrison GM, Mun RP, Cooper G, et al. A note on the effect of polymer rigidity and concentration on spray atomisation. J Non-Newtonian Fluid Mech. 1999;85:93–104.
  • Ochowiak M, Broniarz-Press L, Rozanska S, et al. The experimental analysis of the polyacrylamide solutions effervescent atomization. Proc Eng. 2012;42:1849–1854.
  • Coates MS, Chan HK, Fletcher DF, et al. Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler. Pharm Res. 2007;24:1450–1456.
  • Yang Y, Bajaj N, Xu P, et al. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 2009;30:1947–1953.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.